Expansion of helper T-cell recognition in mice immunized with a synthetic peptide corresponding to the C-terminal thyrotropin receptor-specific insert

Peptides

Volumn 20, Issue 9, 1999, Pages 1085-1090

  Ueda, Michiko ^a   Sugawa, Hideo ^a   Ichiyama, Satoshi ^a   Mori, Toru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Autoimmunity; ELISPOT; Epitope spreading; Helper T cell; Thyrotropin receptor

Indexed keywords

BOVINE SERUM ALBUMIN; SYNTHETIC PEPTIDE; THYROTROPIN RECEPTOR;

ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL TYPE; CONTROLLED STUDY; FEMALE; HELPER CELL; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; FEMALE; INTERFERON TYPE II; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; RECEPTORS, THYROTROPIN; T-LYMPHOCYTES, HELPER-INDUCER;

BOVINAE; UEDA;

EID: 0032868113     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00103-5     Document Type: Article

References (38)

1. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature (Lond). 383:1996;787-793.
2. Akamizu T., Ikuyama S., Saji M., Kosugi S., Kozak C., McBridge W.O., Kohn L.D. Cloning, chromosomal assignment and regulation of the thyrotropin receptor expression of the gene is regulated by thyrotropin, agents that increase cAMP levels, and thyroid autoantibodies . Proc Natl Acad Sci USA. 87:1990;5677-5681.
3. Aoki I., Aoki A., Klinman D.M. Activation of IL-4 and IL-6 secreting cells by antigen. Cytokine. 7:1995;799-805.
4. Chazenbalk G.D., Tanaka K., Nagayama Y., Kakinuma A., Jaume J.C., McLachhlan S.M., Rapoport B. Evidence that the thyrotropin receptor ectodomain contains not one, but two, cleavage sites. Endocrinology. 138:1997;2893-2899.
5. Dahle C., Ekerfelt C., Vrethem M., Samuelsson M., Erenerudh J. T helper type 2-like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillaun-Barre syndrome. J Neurol Sci. 153:1997;54-60.
6. Davies T.F., Platzer M., Schwartz A., Friedman E. Functionality of thyroid-stimulating antibodies assessed by cryopreserved human thyroid cell bioassay. J Clin Endocrinol Metab. 57:1983;1021-1027.
7. Endo T., Ohmori M., Ikeda M., Kotani S., Onaya T. Rabbit antibodies against two different extracellular domains of human thyrotropin receptor possess thyroid stimulating activities. Biochem Biophys Res Commun. 179:1991;1548-1553.
8. Fisfalen M.E., Palmer E.M., Seventer G.A.V., Soltani K., Sawai Y., Kaplan E., Hidaka Y., Ober C., Degroot L.J. Thyrotropin-receptor and thyroid peroxidase-specific T cell clones and their cytokine profile in autoimmune thyroid disease. J Clin Endocrinol Metab. 82:1997;3655-3663.
9. Fujihashi K., McGhee J.R., Beagley K.W., McPherson D.T., McPherson S.A., Huang C.M., Kiyono H. Cytokine-specific ELISPOT assay. Single cell analysis of IL-2, IL-4and IL-6 producing cells. J Immunol Methods. 160:1993;181-189.
10. Furmaniak J., Hashim F.A., Petersen V.B., Beever K., Howells R.D., Rees Smith B. Photoaffinity labeling of the TSH receptor on FRTL5 cells. FEBS Lett. 215:1987;316-322.
11. Gajewsei T.F., Pinnas M., Wong T., Fitch F.W. Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J Immunol. 146:1991;1750-1758.
12. James J.A., Gross T., Scofield R.H., Harley J.B. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization Sm B/B′-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity . J Exp Med. 181:1995;453-461.
13. Kim W.B., Cho B.Y., Park H.Y., Lee H.Y., Kohn L.D., Tahara K., Koh C.S. Epitopes for thyroid-stimulating antibodies in Graves' sera a possible link of heterogeneity to differences in response to antithyroid drug treatment . J Clin Endocrinol Metab. 81:1996;1758-1767.
14. Kohn L.D., Suzuki K., Hoffman W.H., Tombbaccini D., Marcocci C., Shimojo N., Watanabe Y., Amino N., Cho B.Y., Kohno Y., Hirai A., Tahara K. Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease. J Clin Endocrinol Metab. 82:1997;3998-4009.
15. Kosugi S., Sugawa H., Mori T. Epitope analysis of the thyrotropin receptor, 1997. Mol Cell Endocrinol. 128:1997;11-18.
16. Kosugi S., Ban T., Akamizu T., Kohn L.D. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid stimulating antibodies and with thyroid stimulation blocking antibodies in idiopathic myxedema these determinants have no homologous sequence on gonadotropin receptors . Mol Endocrinol. 6:1992;168-180.
17. Kosugi S., Akamizu T., Takai O., Prabhakar B.S., Kohn L.D. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating antibodies. Thyroid. 1:1991;321-330.
18. Lehmann P.V., Forsthuber T., Miller A., Sercarz E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature (Lond). 358:1992;155-157.
19. Liblau R.S., Singer S.M., McDevitt H.O. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today. 16:1995;34-38.
20. McRae B.L., Vanderlugt C.L., Dal-Canto M.C., Miller S.D. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med. 182:1995;75-85.
21. Mori T., Sugawa H., Piraphatdist T., Inoue D., Enomoto T., Imura H. A synthetic oligopeptide derived from human thyrotropin receptor sequence binds to Graves' immunoglobulin and inhibits thyroid stimulating antibody activity but lacks interactions with TSH. Biochem Biophys Res Commun. 178:1991;165-172.
22. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. . J Immunol. 136:1986;2348-2357.
23. Murakami M., Mori M. Identification of immunogenic regions in human thyrotropin receptor from immunoglobulin G of patients with Graves' disease. Biochem Biophys Res Commun. 171:1990;512-518.
24. Nagy E.V., Burch H.B., Lukes Y.G., Car F.E., Kosugi S., Kohn L.D., Burman K.D. Immunogenicity of a unique region of the human thyrotropin receptor. J Endocrinol Invest. 16:1993;485-493.
25. Ohmori M., Endo T., Onaya T. Development of chicken antibodies toward the human thyrotropin receptor peptides and their bioactivities. Biochem Biophys Res Commun. 174:1991;399-403.
26. Piraphatdist T., Sugawa H., Inoue D., Enomoto T., Mori T., Imura H. Possible binding site of thyrotropin binding inhibitor immunoglobulin (TBII) on the thyrotropin (TSH) receptor, which is different from TSH binding site. Biochem Biophys Res Commun. 172:1990;529-536.
27. Roura-Marta C., Catalfamo M., Sospedra M., Alcalde L., Pujol-Borrell R., Jaraqemada D. Single-cell analysis of intrathyroidal lymphocytes shows differential cytokine expression in Hashimoto's and Graves' disease. Eur J Immunol. 27:1997;3290-3302.
28. Russo D, Chazenbalk G. D, Nagayama Y, Wadsworth HL, Seto P, Rapoport B. A new structural model for the thyrotropin receptor as determined by covalent crosslinking of thyrotropin to the recombinant receptor in intact cells: evidence for a single polypeptide chain. Mol Endocrinol 1991;5:1607-12.
29. Sheehan J.C., Hess G.P. A new method of forming peptide bonds. J Am Chem Soc. 77:1955;1067-1068.
30. Simon A.K., Seipelt E., Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA. 91:1994;8562-8566.
31. Sugawa H., Akamizu T., Kosugi S., Ueda Y., Ohta C., Okuda J., Mori T. Presence of heterogeneous thyroid-stimulating antibodies in sera from individual Graves' patients as shown by synthesized thyrotropin receptor peptide application evidence showing two independent epitopes and a possible recognition of two epitopic regions by one antibody molecule . Eur J Endocrinol. 133:1995;283-293.
32. Sugawa H., Ueda Y., Ueda M., Kosugi S., Ichiyama S., Mori T. Immunization with the "immunogenic Peptide" of TSH receptor induces oligoclonal antibodies with various biological activities. Peptide. 19:1998;1303-1307.
33. Sugawa H., Miyamoto M., Higuchi K., Smith E., Mori T., Imura H. Production and properties of novel human thyroid cancer specific monoclonal antibodies. Biochem Biophys Res Commun. 187:1992;404-412.
34. Tahara K., Ban T., Minegishi T., Kohn L.D. Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients. Biochem Biophys Res Commun. 179:1991;70-77.
35. Ueda Y., Sugawa H., Akamizu T., Okuda J., Ueda M., Kosugi S., Ohta C., Kiho Y., Mori T. Thyroid-stimulating antibodies in sera from Graves' patients are heterogeneous in epitope recognition as shown by synthetic human thyrotropin receptor peptides. Eur J Endocrinol. 132:1995;62-68.
36. Vlase H., Weiss M., Graves P.M., Davies T.F. Characterization of murine immune response to the murine TSH receptor ectodomein induction of hypothyroidism and TSH receptor antibodies . Clin Exp Immunol. 113:1998;111-118.
37. Vlase H., Nakashima M., Graves P.N., Tomer Y., Morris J.C., Davies T.F. Defining the major antibody epitopes on the human thyrotropin receptor in immunized mice evidence for intramolecular epitope spreading . Endocrinology. 136:1996;4415-4423.
38. Wadsworth H.L., Chazenbalk G.D., Nagayama Y., Russo D., Rapoport B. An insertion in the human thyrotropin receptor critical for high affinity hormone binding. Science. 249:1990;1423-1425.